Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-03
DOI
10.1038/s41467-020-17139-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The landscape of cancer cell line metabolism
- (2019) Haoxin Li et al. NATURE MEDICINE
- Neutralizing the Detrimental Effect of an N-Hydroxysuccinimide Quenching Reagent on Phosphopeptide in Quantitative Proteomics
- (2018) Yumi Kwon et al. ANALYTICAL CHEMISTRY
- Comprehensive and sensitive proteogenomics data analysis strategy based on complementary multi-stage database search
- (2018) Inamul Hasan Madar et al. INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
- WHO 2016 Classification of gliomas
- (2018) P. Wesseling et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- An anatomic transcriptional atlas of human glioblastoma
- (2018) Ralph B. Puchalski et al. SCIENCE
- PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
- (2018) Carmen Mecca et al. Frontiers in Cellular Neuroscience
- Human glioblastoma arises from subventricular zone cells with low-level driver mutations
- (2018) Joo Ho Lee et al. NATURE
- Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
- (2018) Jin-Ku Lee et al. NATURE GENETICS
- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- IDH1 Mutation and World Health Organization 2016 Diagnostic Criteria for Adult Diffuse Gliomas: Advances in Surgical Strategy
- (2017) Kensuke Tateishi et al. NEUROSURGERY
- Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples
- (2017) Nikita Gahoi et al. Proteomics Clinical Applications
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Proteogenomic characterization and integrative analysis of glioblastoma multiforme
- (2017) Ying-Chun Song et al. Oncotarget
- Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
- (2017) Spyros Darmanis et al. Cell Reports
- Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
- (2016) Daniel R. Wahl et al. CANCER RESEARCH
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
- (2016) Gregg L Semenza EMBO JOURNAL
- Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades
- (2016) Arthur William Alvarenga et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- OmniPath: guidelines and gateway for literature-curated signaling pathway resources
- (2016) Dénes Türei et al. NATURE METHODS
- The MaxQuant computational platform for mass spectrometry-based shotgun proteomics
- (2016) Stefka Tyanova et al. Nature Protocols
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- PKM2 and cancer: The function of PKM2 beyond glycolysis
- (2016) GAOCHAO DONG et al. Oncology Letters
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- Dynamic profiling of the protein life cycle in response to pathogens
- (2015) M. Jovanovic et al. SCIENCE
- The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation
- (2014) Remco J. Molenaar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Off-Line High-pH Reversed-Phase Fractionation for In-Depth Phosphoproteomics
- (2014) Tanveer S. Batth et al. JOURNAL OF PROTEOME RESEARCH
- Proteogenomic characterization of human colon and rectal cancer
- (2014) Bing Zhang et al. NATURE
- Compact variant-rich customized sequence database and a fast and sensitive database search for efficient proteogenomic analyses
- (2014) Heejin Park et al. PROTEOMICS
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells
- (2013) Jenna Kahn et al. NEURO-ONCOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Gross Total Resection of Glioma with the Intraoperative Fluorescence-guidance of Fluorescein Sodium
- (2012) Bo Chen et al. International Journal of Medical Sciences
- Cortactin in cell migration and cancer at a glance
- (2012) S. M. MacGrath et al. JOURNAL OF CELL SCIENCE
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Standards of care for treatment of recurrent glioblastoma—are we there yet?
- (2012) Michael Weller et al. NEURO-ONCOLOGY
- HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
- (2011) L Qiang et al. CELL DEATH AND DIFFERENTIATION
- Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
- (2011) Amparo Wolf et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
- (2010) Panagiotis A. Konstantinopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
- (2010) François Ducray et al. Molecular Cancer
- Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
- (2010) Daniele Merico et al. PLoS One
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
- (2009) A Arlt et al. ONCOGENE
- Successive and Selective Release of Phosphorylated Peptides Captured by Hydroxy Acid-Modified Metal Oxide Chromatography
- (2008) Yutaka Kyono et al. JOURNAL OF PROTEOME RESEARCH
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More